Oracle, Dell Dip in Thursday’s Market Cap Stock Movers By Investing.com

Thursday’s trading session is witnessing notable fluctuations among stocks across the board, with significant movements in both the mega-cap and large-cap categories. Oracle Corp (NYSE:) and Dell Inc (NYSE:) are among the stocks experiencing declines, while MicroStrategy Inc (NASDAQ:) is surging. Here’s a look at some of the key stock movers today, spanning from mega-caps to small caps.

Mega-Cap Movers (Market Cap $200B+):

• Oracle Corp (ORCL): -4.03%
• Salesforce Com (NYSE:): -3.84%
• Avago Technologies (NASDAQ:): -3.08%
• Servicenow Inc (NYSE:): -2.68%
• Adobe Sys Inc (NASDAQ:): -2.21%

Large-Cap Stock Movers (Market Cap $10B-$200B):

• Dell Inc (DELL): -12.25%
• Hewlett-pack (NYSE:): HP stock downgraded to Hold by HSBC on weak 1QFY25 outlook and rising commodity costs; -11.36%
• MicroStrategy Inc (MSTR): +9.94%
• Autodesk Inc (NASDAQ:): -8.59%
• Nutanix Inc (NASDAQ:): Nutanix to Present at Upcoming Investor Conference; -7.81%
• BeiGene (NASDAQ:): +7.31%
• Reinvent Technology Partners Y (AUR): +7.27%
• Li Auto Inc (NASDAQ:): American Lithium Reports Results of Annual General and Special Meeting; +6.78%
• IBIT NASDAQ (IBIT): +6.44%
• FBTC NYSE (FBTC): +6.37%

Mid-Cap Stock Movers (Market Cap $2B-$10B):

• SVF Investment 3 (SYM): -35.87%
• Iris Energy (IREN): +29.71%
• Arrowhead Research Corp (NASDAQ:): +24.23%
• Urban outfitters (NASDAQ:): +18.31%
• Hut 8 PK (HUT): +16.5%
• HCM Acquisition (MRNO): +16.17%
• Good Works Acquisition (CIFR): +14.56%
• MSTU (MSTU): +13.93%

Small-Cap Stock Movers (Market Cap $300M-$2B):

• Advanced Photonix Inc (API): +33.97%
• ETHU (ETHU): +18.79%
• Golden Bull (BTBT): +18.45%
• Fate Therap (NASDAQ:): +18.28%
• Kingsoft Cloud Holdings Ltd (KC): +17.42%
• Immunome Inc (NASDAQ:): +16.83%
• Wowo Ltd (MFH): -16.32%
• Semler Scientifc (NASDAQ:): +16.06%
• Applied Therapeutics Inc (NASDAQ:): FDA declines approval for Applied Therapeutics’ Galactosemia drug; -16.06%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.